Protective immunity ehcited by recombinant bacille calmette-guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: A candidate lyme disease vaccine

Journal of Experimental Medicine

Volumn 178, Issue 1, 1993, Pages 197-209

  Stover, C Kendall ^a   Bansal, Geetha P ^a   Hanson, Mark S ^a   Burlein, Jeanne E ^a   Palaszynski, Susan R ^a   Young, James F ^a   Koenig, Scott ^a   Young, Douglas B ^c   Sadziene, Ariadna ^b   Barbour, Alan G ^b  

^a Medlmmune Inc   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; LIPOPROTEIN A;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BCG VACCINATION; CELL SURFACE; GENETIC RECOMBINATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LYME DISEASE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BCG VACCINE; BORRELIA BURGDORFERI GROUP; FEMALE; LIPOPROTEINS; LYME DISEASE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; RECOMBINANT FUSION PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; VACCINATION; VACCINES, SYNTHETIC;

EID: 0027254484     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.1.197     Document Type: Article

References (50)

1. Stover, C.K., V.F. de la Cruz, T.R. Fuerst, J.E. Burlein, I.A. Benson, L.T. Bennett, G.P. Bansal, J.F. Young, M.H. Lee, J.F. Hatfull et al. 1991. New use of BCG for recombinant vaccines. Nature (Lond.). 351:456.
2. Aldovini, A., and R.A. Young. 1991. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature (Lond.). 351:479.
3. Jacobs, W.R., Jr., S.B. Snapper, L. Lugosi, and B.R. Bloom. 1990. Development of BCG as a recombinant vaccine delivery vehicle. Curr. Top Microbiol. Immunol. 155:153.
4. Jacobs, W.R., M. Tuckman, and B.R. Bloom. 1987. Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature (Lond.). 327:532.
5. Snapper, S.B., L. Lugosi, A. Jekkel, R.E. Melton, T. Kieser, B.R. Bloom, and W.R. Jacobs, Jr. 1988. Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc. Natl. Acad. Sci. USA. 85:6987.
6. Newton, S.M., CO. Jacob, and B.A. Stocker. 1989. Immune response to cholera toxin epitope inserted in Salmonella flageUin. Science (Wash. DC). 244:70.
7. Schorr, J., B. Knapp, E. Hundt, H. Kupper, and E. Amann. 1991. Surface expression of malarial antigens in E. coli and S. typhimurium: induction of serum antibody response upon oral vaccination of mice. In Vaccines 91. Modern Approaches to New Vaccines Including Prevention of AIDS. R.A. Lemer, R.M. Channock, H.S. Ginsberg, and F. Brown, editors. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 387-392.
8. Pistor, S., and G. Hobom. 1988. Expression of viral hemag-glutinin on the surface of E. coli. Klin. Wochenschr. 66:110.
9. Bakker, D., F.G. van Zijderveld, S. van der Veen, B. Oudega, and F.K. de Graaf. 1990. K88 fimbriae as carriers of heterologous antigenic determinants. Microb. Pathog. 8:343.
10. Charbit, A., J.C. Boulain, A. Ryter, and M. Hofhung. 1986. Probing the topology of a bacterial membrane protein by genetic insertion of a foreign epitope: expression at the cell surface. EMBO (Eur. Mol. Biol. Organ.) J. 5:3029.
11. Hayashi, S., and H.C. Wu. 1990. Lipoproteins in bacteria. J. Bioenerg. Biomembr. 22:451.
12. Reiterman, A., J. Metzger, K.-H. Wiesmuller, G. Jung, and W.G. Bessler. 1989. Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten. Biol. Chem. Hoppe-Syler. 370:343.
13. Deres, K., H. Schild, K.-H. Wiesmuller, G. Jung, and H.-G. Ramensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (Lond.). 342:561.
14. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J. Exp Med. 142:473.
15. Brandt, M.E., B.S. Riley, J. Radolf, and M.V. Norgard. 1990. Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect. Immun. 58:983.
16. Chamberlain, N.R., M.E. Brandt, A.L. Erwin, J.D. Radolf, and M.V. Norgard. 1989. Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect. Immun. 57:2872.
17. Finke, M., M. Duchene, A. Eckhardt, H. Domdey, and B.U. von Specht. 1990. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli. Infect. Immun. 58:2241.
18. Green, B.A., T. Quinn-Dey, and G.W. Zlotnick. 1987. Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect. Immun. 55:2878.
19. Hoehn, G.T., and V.L. Clark. 1992. The major anaerobically induced outer membrane protein of Neisseria gonorrhoeae, Pan 1, is a lipoprotein. Infect. Immun. 60:4704.
20. Seilwood, R., K.A. Kent, M.R. Burrows, R.J. Lysons, and A.P. Bland. 1989. Antibodies to a common outer envelope antigen of Treponema hyodysenteriae with antibacterial activity. J. Gen. Microbiol. 135:2249-2257.
21. Sjostedt, A., G. Sandstrom, and A. Tarnvik. 1992. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis. Infect. Immun. 60:2855.
22. Thomas, W., and R. Sellwood. 1993. Molecular cloning, expression, and DNA sequence analysis of the gene that encodes the 16-kilodalton outer membrane lipoprotein of Serpulina kyo-dysenteriae. Infect. Immun. 61:1136.
23. Howe, T.R., L.W. Mayer, and A.G. Barbour. 1985. A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science (Wish. DC). 227:645-646.
24. Howe, T.R., L.F.R. Lo Quier, and A.G. Barbour. 1986. Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. Infect. Immun. 54:207.
25. Bergstrom, S., V. Bundoc, and A.G. Barbour. 1989. Molecular analysis of linear plasmid encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 3:479.
26. Simon, M.M., U.E. Schaible, M.D. Kramer, C. Eckerson, C. Museteanu, H.K. Muller-Hermelink, and R. Wallich. 1991. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164:123.
27. Fikrig, E., S.W. Barthold, F.S. Kantor, and R. Flavell. 1990. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science (Wish. DC). 250:553.
28. Fikrig, E., S.W. Barthold, N. Marcantonio, K. Deponte, F.S. Kantor, and R. Flavell. 1992. Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 60:657.
29. Fikrig, E., S.R. Telford, S.W. Barthold, F.S. Kantor, A. Spielman, and R.A. Flavell. 1992. Elimination of Borrelia burgdorferi from vectors ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. USA. 89:5418.
30. Dunn, J.J., B.N. Lade, and A.G. Barbour. 1990. Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expression Purif. 1:159.
31. Erdile, L.F., M. Brandt, D.J. Warakomski, G.J. Westrack, A. Sadziene, A.G. Barbour, and J.P. Mays. 1993. Role of Attached Lipid in Immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61:81.
32. Bordier, C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1604.
33. Radolf, J.D., N.R. Chamberlain, A. Clausell, and M.V. Nor-gard. 1988. Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp pallidum by phase partitioning with the nonionic detergent Triton X-114. Infect. Immun. 56:490.
34. Sadziene, A., P.A. Thompson, and A.G. Barbour. 1993. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J. Infect. Dis. 167:165.
35. Schwan, T.G., W. Burgdorfer, M. E. Crumpf, and R.H. Karstens. 1988. The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-footed mice (Peromyscus leucopus). J. Clin. Microbiol. 26:893.
36. Bansal, G., unpublished data manuscript in preparation.
37. Bothamley, G.H., R. Rudd, F. Festenstein, and j. Ivanyi. 1992. Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary infections. Thorax. 47:270.
38. Oftung, F., A.S. Mustafa, R. Husson, R.A. Young, and T. Goda. 1987. Human T cell clones recognized two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli. J. Immunol. 138:927.
39. Ashbridge, K.R., R.J. Booth, J.D. Watson, and R.B. Lathigra. 1989. Nucleotide sequence of the 19 kDa antigen gene from Mycobacterium tuberculosis. Nucleic Acids Res. 17:1249.
40. Young, D.B., and T.R. Garbe. 1991. Lipoprotein antigens of Mycobacterium tuberculosis. Res. Microbiol. 142:55.
41. Matsuo, K., R. Yamaguchi, A. Yamazaki, H. Tasaka, and T. Yamada. 1988. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular cr-antigen. J. Bacteriol. 170:3847.
42. Borremans, M., L. De Wit, G. Volkaert, J. Ooms, J. de Bruyn, K. Huygen, J. van Vooren, M. Steladndre, R. Verhofstadt, and J. Content. 1989. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect. Immun. 57:3123.
43. Wiker, H.G., K. Sletten, S. Nagai, and M. Harboe. 1990. Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex. Infect. Immun. 58:272.
44. Matsuo, K., R. Yamaguchi, A. Yamazaki, H. Tasaka, K. Ter-asaka, and T. Yamada. 1990. Cloning and expression of the gene for the cross-reactive α antigen of Mycobacterium hansassii. Infect. Immun. 58:550.
45. Matsuo, K., R. Yamaguchi, A. Yamazaki, H. Tasaka, K. Ter-asaka, M. Totsuka, K. Kobayashi, H. Yukitake, and T. Yamada. 1990. Establishment of a foreign antigen secretion system in mycobacteria. Infect. Immun. 58:4049.
46. Gros, P., E. Skamene, and A. Forget. 1981. Genetic control of natural resistance to mycobacterium bovis (BCG) in mice. J. Immunol. 127:2417.
47. Wilske, B., V. Preac-Mursic, G. Schierz, R. Kuhbeck, A.G. Barbour, and M. Kramer. 1988. Antigenic variability of Borrelia burgdorferi. Ann. NY Acad. Sci. 539:126.
48. Barthold, S.W. 1991. Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J. Infect. Dis. 163:419.
49. Piesman, J., J.R. Oliver, and R.J. Sinsky. 1990. Growth kinetics of the lyme disease spirochete (Borrelia burgdorferi) in vector ticks (Ixodes dammini). Am. J. Trop Med. Hyg. 42:353.
50. Andersen, A.B., and E.B. Hansen. 1989. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular weight protein of Mycobacterium tuberculosis. Infect. Immun. 57:2481.